Relevant bibliographies by topics / Therapeutic ERCP

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Therapeutic ERCP'

Author: Grafiati
Published: 11 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Therapeutic ERCP.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Therapeutic ERCP"

1

Enns, R., MA Eloubeidi, K. Mergener, PS Jowell, MS Branch, and J. Baillie. "Predictors of Successful Clinical and Laboratory Outcomes in Patients with Primary Sclerosing Cholangitis Undergoing Endoscopic Retrograde Cholangiopancreatography." Canadian Journal of Gastroenterology 17, no. 4 (2003): 243–48. http://dx.doi.org/10.1155/2003/475603.

Full text
Abstract:
Endoscopic retrograde cholangiopancreatography (ERCP) in patients with primary sclerosing cholangitis (PSC) can be a challenging and sometimes gratifying opportunity for therapeutic intervention. Although there often appears to be initial radiological improvement after ERCP, the benefit as measured by serial estimations of subsequent liver enzymes is questionable. The fluctuating course of the inflammatory process makes the interpretation of serology even more difficult.OBJECTIVES: To document and compare the liver profile and clinical status of patients before and after diagnostic and therapeutic ERCP; to determine predictors of clinical and laboratory success in patients with PSC; and to assess the complication rate of diagnostic and therapeutic ERCP in these patients.METHODS: All patients with PSC who underwent ERCP at the authors’ medical centres between January 6, 1987 and January 12, 1998 were identified using a computerized database. Presenting symptoms, liver enzymes (aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase) and bilirubin were recorded before ERCP. Clinical success was defined as resolution of the presenting symptoms. Laboratory success was defined as improvement in two of three liver enzymes by at least 50%, or resolution of jaundice.RESULTS: One hundred four patients underwent 204 ERCPs of which 56 ERCPs were diagnostic. Clinical improvement was seen in 35% of the patients after diagnostic ERCP and in 70% after therapeutic procedures (Χ2=18.4, P=0.001). Laboratory improvement was seen in 35% of patients undergoing diagnostic ERCP and in 52% of the patients undergoing therapeutic ERCP (P=0.04). The reductions in liver enzymes were significant in both the diagnostic and therapeutic groups. Serum bilirubin level decreased significantly in the therapeutic ERCP group only. In a univariate analysis, patients with common bile duct strictures, any dominant stricture and those who underwent a therapeutic procedure were most likely to have clinical and laboratory improvement. In multivariable logistic regression, the presence of a dominant stricture, endoscopic therapy and high serum bilirubin were all independent predictors of a successful clinical outcome. There was no difference in total complication rates (18% versus 14%) when comparing the diagnostic and therapeutic ERCP groups. However, all seven severe complications occurred in the therapeutic ERCP group.CONCLUSIONS: First, in PSC, clinical and laboratory improvement is more common in patients undergoing therapeutic ERCP than diagnostic ERCP. Second, aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase improve following both diagnostic and therapeutic ERCP, and should therefore not be relied upon to determine the success of the procedure. Third, bilirubin levels decreased in the therapeutic group but remained unchanged in the diagnostic group, suggesting that the serum bilirubin level may be a more sensitive indicator of successful therapeutic intervention than transaminases. Fourth, common bile duct strictures, dominant strictures and bilirubin levels are important variables in determining the success of an ERCP in PSC. Finally, complication rates after therapeutic ERCP are similar to those after diagnostic ERCP in PSC patients. However, severe complications occur more commonly in the therapeutic group.
APA, Harvard, Vancouver, ISO, and other styles
2

Jones, Wesley B., Joseph Blackwell, Brian McKinley, and Steven Trocha. "What is the Risk of Diagnostic Endoscopic Retrograde Cholangiopancreatography before Cholecystectomy?" American Surgeon 80, no. 8 (August 2014): 746–51. http://dx.doi.org/10.1177/000313481408000821.

Full text
Abstract:
Many surgeons prefer to perform endoscopic retrograde cholangiopancreatography (ERCP) before cholecystectomy, specifically in patients at significant risk of having biliary pathology. However, a preoperative diagnostic ERCP, without the use of an endoscopic ultrasound or magnetic retrograde cholangiopancreatoscopy, remains controversial. This is the result of the risk of either performing an unnecessary procedure and/or the development of post-ERCP pancreatitis (PEP). We performed a retrospective review of all surgeon-performed ERCPs at our institution between July 2011 and May 2013. This was done to examine patients who had pericholecystectomy ERCP. We had 550 ERCPs performed at our institution during this time period, 169 of which were pericholecystectomy procedures. We divided the 169 patients who had a diagnostic procedure (Diagnostic group) from those who had known biliary pathology before intervention (Therapeutic group). As a result, 34 patients (20.1%) were placed in the Diagnostic group and 135 patients (79.9%) in the Therapeutic group. Of the 34 Diagnostic patients, four (11.8%) developed PEP. Fifteen (44.1%) had unnecessary procedures, two of which had PEP (2.9%). Of the 135 ERCPs in the Therapeutic group, 18 patients (13.4%) developed PEP. Five of the 11 who had unnecessary procedures developed PEP. Based on the low incidence of complications, diagnostic ERCP has an acceptable rate of pancreatitis and/or unnecessary procedures when performed in highly selected patients and before cholecystectomy when compared with patients undergoing therapeutic ERCP. However, more aggressive use of diagnostic imaging before ERCP should be adopted given the number of unnecessary procedures performed.
APA, Harvard, Vancouver, ISO, and other styles
3

Choudhury, Bikash Narayan, Utpal Jyoti Deka, Bhaskar Jyoti Baruah, Mallika Bhattachayya, Preeti Sarma, and Porag Debroy. "Indications, outcomes and complications of therapeutic endoscopic retrograde cholangiopancreatography procedures in a tertiary care centre in North East India." International Journal of Research in Medical Sciences 8, no. 7 (June 26, 2020): 2606. http://dx.doi.org/10.18203/2320-6012.ijrms20202903.

Full text
Abstract:
Background: Therapeutic endoscopic retrograde cholangiopancreatography (ERCP) is one of the most complex endoscopic procedures in the management of several pancreatobiliary diseases. There is no comprehensive data available till date about ERCP procedures from North East India. The aim of this study was to review the indications, outcomes and complications of endoscopic retrograde cholangiopancreatography (ERCP) procedures in a tertiary care centre of North East India.Methods: We retrospectively analysed the clinical records of all patients undergoing ERCP between July 2011 and November 2019. ERCP was performed under sedation (Midazolam + Pentazocine). Patient’s demographic characters, ERCP indications, outcome and post-ERCP complications were reviewed. Potential important patient and procedure related risk factors for overall post-ERCP complications were investigated.Results: A total 1038 patients were included in the study. Cannulation of the desired duct was successful in 89.2% of ERCPs. Among them male patients were 392 and females were 646. Mean age was 45 years and the age range were 7 to 92 years. Commonest indication was choledocholithiasis followed by malignancy. Overall Success rate was 82.66% with 84.64% in CBD stone and 75.65% in stenting of malignancy. Post ERCP complications developed in 96 patients (9.2%) and pancreatitis was the most common post-ERCP complication. Sedation related complications occurred only in few cases.Conclusions: Despite its associated morbidity and risk of mortality, ERCP is an important method for managing the pancreatic-biliary diseases. Indications, outcomes, and complications of therapeutic ERCPs in our centre are comparable to those reported from other centres.
APA, Harvard, Vancouver, ISO, and other styles
4

Yoon, Seung Bae, Jungmee Kim, Chang Nyol Paik, Jun Kyu Lee, Dong Kee Jang, Won Jae Yoon, Jung-Wook Kim, Byoung Kwan Son, Tae Hee Lee, and Jae-Young Jang. "Trends and Characteristics of Endoscopic Retrograde Cholangiopancreatography: A Nationwide Database Study in Korea." Korean Journal of Pancreas and Biliary Tract 26, no. 3 (July 31, 2021): 186–94. http://dx.doi.org/10.15279/kpba.2021.26.3.186.

Full text
Abstract:
Background/Aim: Endoscopic retrograde choangiopancreatography (ERCP) has been established as an effective tool for the diagnosis and treatment of pancreatobiliary diseases. However, after the evolution for more than 4 decades, nationwide data on current trends and characteristic is not well known. Therefore, we conducted an analysis of nationwide database to determine the number and status of ERCP performed in Korea. Methods: We used the nationwide claims database, Korean Health Insurance Review and Assessment between 2012 and 2015. We investigated the frequencies and characteristics of ERCP procedure performed as well as demographics of the patients. Results: A total of 158,038 ERCP procedures were performed in 114,757 patients during study period. The number of total ERCPs increased every year, and especially the rate of therapeutic ERCPs is on the increased trend. About two-thirds of ERCPs (63.3%) were performed in high-scaled hospitals. In 2015, the proportion of elderly patients over 80 years old increased compared to that in 2011, from 14.3% to 17.2%. Conclusions: The annual number of ERCPs performed is increasing in Korea. With increasing ERCP for therapeutic purposes or for older patients, more attention should be paid to safety for patients.
APA, Harvard, Vancouver, ISO, and other styles
5

Jones, Wesley B., Richard H. Roettger, William S. Cobb, and Alfredo M. Carbonell. "Endoscopic Retrograde Cholangiopancreatography in General Surgery: How Much are We Outsourcing?" American Surgeon 75, no. 11 (November 2009): 1050–53. http://dx.doi.org/10.1177/000313480907501104.

Full text
Abstract:
Although surgeons can safely perform endoscopic retrograde cholangiopancreatography (ERCP), it has fallen within the domain of gastroenterologists. We sought to quantify the role of ERCP in a tertiary-care surgery department. The hospital discharge database was queried for all ERCPs performed from January 2007 to December 2007. Gastroenterologists performed all ERCPs in our query. Surgical patients were admitted and/or under the care of a surgeon; whereas nonsurgical patients had no surgeon involvement. Patient characteristics and diagnoses were compared between groups. ERCP procedural details were recorded. Surgical patients comprised 48 per cent (n = 151) of the total 311 ERCPs performed. The mean time interval from a surgeon's request for ERCP to actual procedure was 2.43 days (standard deviation [SD] 2.55; range, 0-13 days). The surgical group had significantly different diagnoses and underwent less diagnostic (22% vs 56%) and more therapeutic ERCPs (72% vs 38%). Surgical patients were more likely inpatients (82.1% vs 16.8%) with a longer length of stay (6.7 vs 3.9 days; P = 0.0029) compared with nonsurgical patients. We found surgical patients requiring ERCP differ significantly from nonsurgical patients, with a significant number of technical interventions being outsourced. Given the benefits of a surgical ERCP program and the potential volume of these unique patients, this procedure should be performed by appropriately trained surgeons.
APA, Harvard, Vancouver, ISO, and other styles
6

Navaneethan, Udayakumar, Basile Njei, Xiang Zhu, Kiran Kommaraju, Mansour Parsi, and Shyam Varadarajulu. "Safety of ERCP in patients with liver cirrhosis: a national database study." Endoscopy International Open 05, no. 04 (April 2017): E303—E314. http://dx.doi.org/10.1055/s-0043-102492.

Full text
Abstract:
Abstract Background and aims Given the limited data on the safety of endoscopic retrograde cholangiopancreatography (ERCP) in patients with liver cirrhosis, we attempted to evaluate this question using a large national database. Methods We conducted a matched case – control study using the 2010 National Inpatient Sample database in which four non-cirrhotic controls were matched randomly for every cirrhotic patient from the same 10-year age group. We compared adverse events and safety of inpatient ERCP between patients with (n = 3228) and without liver cirrhosis (controls, n = 12 912). Results Of the 3228 cirrhotic patients, 2603 (80.6 %) had decompensated and 625 (19.4 %) had compensated disease. Post-procedure bleeding (2.1 % vs. 1.2 %, P < 0.01) was higher in patients compared to controls. On multivariable analysis, decompensated cirrhosis (adjusted odds ratio [aOR], 2.7; 95 % confidence interval [CI], 2.2 – 3.2), compensated cirrhosis (aOR 2.2; 95 %CI 1.2 – 3.9), therapeutic ERCPs (aOR 1.4; 95 % CI 1.2 – 2.1), and biliary sphincterotomy (aOR 1.6; 95 %CI 1.1 – 2.1) were independently associated with increased risk of post-procedure bleeding. Performing ERCPs in large (aOR 0.5; 95 %CI 0.4 – 0.6) and medium (aOR 0.7; 95 %CI 0.6 – 0.9) sized hospitals was associated with a decreased risk of post-procedure bleeding. Biliary sphincterotomy (aOR 1.7; 95 %CI 1.2 – 2.3) and therapeutic ERCPs (aOR 1.1; 95 %CI 1.1 – 1.3) increased the risk of post-ERCP pancreatitis, and pancreatic stent placement was associated with a decreased risk of post-ERCP pancreatitis (aOR 0.8; 95 %CI 0.7 – 0.9). Conclusions Cirrhosis (both compensated and decompensated), performing therapeutic ERCPs and biliary sphincterotomy increase the risk of post-procedure bleeding. Performing ERCPs in large and medium sized hospitals may improve outcomes.
APA, Harvard, Vancouver, ISO, and other styles
7

Mesenas, Steven J. "Does the Advent of Endoscopic Ultrasound (EUS) Sound the Death Knell for Endoscopic Retrograde Cholangiopancreatography (ERCP)?" Annals of the Academy of Medicine, Singapore 35, no. 2 (February 15, 2006): 89–95. http://dx.doi.org/10.47102/annals-acadmedsg.v35n2p89.

Full text
Abstract:
Introduction: Endoscopic retrograde cholangiopancreatography (ERCP) has been the premier diagnostic and therapeutic endoscopic procedure in the management of pancreatic and biliary diseases (PBD). The use of endoscopic ultrasound (EUS), including EUS-guided fine needle aspiration (FNA), of pancreatic and biliary tumours has become more widely available in the last decade and has gradually replaced diagnostic ERCP. Together with EUS, other imaging modalities like magnetic resonance cholangiopancreatography (MRCP) have resulted in a decrease in the number of ERCPs. With the advent of interventional EUS, ERCP is at risk of being completely eclipsed. Methods: A search of all relevant articles on EUS and ERCP from Medline and peer-reviewed journals. Results: This review article examines the exact place of ERCP and EUS and their relative contributions in the management algorithm of PBD. Conclusion: Although diagnostic EUS, including EUS-guided FNA, is well established in the evaluation of PBD, interventional EUS is still in its infancy and its true potential is unknown. Therefore, therapeutic ERCP still has a vital, albeit smaller role to play in the treatment of pancreatic and biliary diseases. Key words: Biliary diseases, Endoscopic retrograde cholangiopancreatography, Endosonography, Pancreatic
APA, Harvard, Vancouver, ISO, and other styles
8

Tham, Tony C. K., Jo Vandervoort, Richard C. K. Wong, David R. Lichtenstein, Jacques Van Dam, Fred Ruymann, Frank Farraye, and David L. Carr-Locke. "Therapeutic ERCP in outpatients." Gastrointestinal Endoscopy 45, no. 3 (March 1997): 225–30. http://dx.doi.org/10.1016/s0016-5107(97)70263-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kröner, Paul T., Mohammad Bilal, Ronald Samuel, Shifa Umar, Marwan S. Abougergi, Frank J. Lukens, Massimo Raimondo, and David L. Carr-Locke. "Use of ERCP in the United States over the past decade." Endoscopy International Open 08, no. 06 (May 25, 2020): E761—E769. http://dx.doi.org/10.1055/a-1134-4873.

Full text
Abstract:
Abstract Background and study aims With newer imaging modalities, indications for use of endoscopic retrograde cholangiopancreatography (ERCP) have changed in the last decade. Despite advances in ERCP, paucity in recent literature regarding utilization and outcomes of ERCP exists. Thus, the aim of this study was to assess the inpatient use of ERCP, outcomes, and most common indications. Patients and methods Retrospective-cohort study using the Nationwide Inpatient Sample 2007–2016. All patients with ICD9–10CM procedural codes for ERCP were included. The primary outcome was the use of ERCP. Secondary outcomes included determining procedural specifics (stenting, sphincterotomy and dilation), complications (post-ERCP pancreatitis [PEP], bile duct perforation), hospital length of stay, total hospital costs and charges. Multivariate regression analysis was used to adjust for confounders. Results A total of 1,606,850 patients underwent inpatient ERCP. The mean age was 59 years (60 % female). The total number of ERCPs increased over the last decade. Patients undergoing ERCP in 2016 had greater odds of undergoing bile duct stent placement, pancreatic duct (PD) stenting, biliary dilation, pancreatic sphincterotomy, PEP and biliary perforation. Inpatient mortality decreased. Hospital charges increased, while length of stay (LOS) decreased. Conclusions The number of ERCPs increased in the past decade. Odds of therapeutic interventions and complications increased. The most common principal diagnoses were choledocholithiasis and gallstone-related AP. Hence, physicians must be aware to promptly diagnose and treat complications. These findings may reflect the increased case complexity and fact that ERCP continues to evolve into an increasingly interventional tool, contrasting from its former role as a predominantly diagnostic and gallstone extraction tool.
APA, Harvard, Vancouver, ISO, and other styles
10

Das, Chittaranjan, Ashis Saha, Faruk Hossain, Md Mokhlesur Rahman, Rakibul Hasan, and AHM Towhidul Alam. "Efficacy of endoscopic retrograde cholangiopancreato-graphy in elderly patients." Bangladesh Medical Journal 45, no. 1 (July 30, 2016): 44–46. http://dx.doi.org/10.3329/bmj.v45i1.28967.

Full text
Abstract:
The incidence of biliary tract pathologies increases as the population ages leading to an increase in the demand of therapeutic use of endoscopic retrograde cholangiopancreatography (ERCP). This study was carried out to assess the effectiveness of therapeutic ERCP in elderly patients. It was a prospective observational study. Patients aged 65 years or more referred for therapeutic ERCP from July 2007 to June 2008 were reviewed by a preformed data sheet which included all the relevant details of the procedure. It was collected at the time of ERCP & before discharge. Of 67 patients audited, successful therapeutic ERCP was performed in 91.04% cases. Our study showed that ERCP was effective in the elderly patients.Bangladesh Med J. 2016 Jan; 45 (1): 44-46
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Therapeutic ERCP"

1

Camberlein, Virgyl. "Target-guided synthesis of metalloenzymes ligands with therapeutic applications." Thesis, Université de Lille (2022-....), 2022. http://www.theses.fr/2022ULILS004.

Full text
Abstract:
La synthèse guidée par la cible de ligands protéiques est une stratégie innovante pour découvrir des composés bioactifs. En particulier, la Kinetic Target-Guided Synthesis (KTGS) and the Dynamic Combinatorial Chemistry (DCC) ont permis, ces dernières années, de découvrir des ligands originaux pour des cibles thérapeutiques mal explorées, ce qui a permis de lancer des projets de découverte de médicaments. Ce projet de thèse vise à utiliser la KTGS pour découvrir, puis optimiser des ligands de deux classes de métalloenzymes que sont les aminopeptidases du réticulum endoplasmiques (ERAP) et l’élastase LasB de la bactérie Pseudomonas aeruginosa. Les ERAPs (1 et 2) participent au processus de maturation des antigènes. Ces enzymes clivent les précurseurs peptidiques en peptides antigéniques matures afin que ceux-ci disposent d’une taille optimale pour leur complexation au complexe majeur d’histocompatibilité de classe I et ainsi initient ou non la réponse immunitaire adaptative. Les niveaux d’expression de ces protéases ainsi que des polymorphismes d’un seul nucléotide ont été associé au développement de cancers et de maladies auto-immunes. Ainsi, la modulation de ces enzymes permettrait de lutter contre les pathologies associées au système immunitaire. P. aeruginosa est une bactérie Gram negative dotée d’une virulence et d’une résistance aux antimicrobiens remarquable. Aujourd’hui, la résistance aux antibiotiques représente un enjeu de santé publique majeur et il y a un besoin urgent en nouvelles thérapeutiques. Afin de satisfaire ce besoin, de nouvelles stratégies sont apparues comme celle consistant à cibler la virulence des bactéries afin de « désarmer » celles-ci. LasB représente une cible thérapeutique de choix de par sa localisation extracellulaire et ses implications physiopathologiques (colonisation, invasion, évasion à la réponse immunitaire, formation de biofilm, etc.). Bien qu'il y ait un besoin médical évident non satisfait dans ces deux aires thérapeutiques, aucun modulateur des ERAPs ni de LasB n'a atteint le marché. Ainsi, l’utilisation de la stratégie KTGS suivie de phases d’optimisation nous ont permis d’identifier et optimiser de nouvelles familles de ligands de ces enzymes. Ces composés peuvent être considérés comme des leads prometteurs puisqu’ils présentent des affinités nanomolaires pour leurs cibles respectives, des profils de sélectivité et de toxicité ainsi que des propriétés physicochimiques remarquables
Target-guided synthesis of protein ligands is an innovative strategy to discover bioactive compounds. In particular, the Kinetic Target-Guided Synthesis (KTGS) and the Dynamic Combinatorial Chemistry (DCC) have allowed, in recent years, the discovery of novel ligands for poorly explored therapeutic targets, which has enabled drug-discovery projects. This thesis project aims at using KTGS to discover and optimize ligands for two classes of metalloenzymes, namely endoplasmic reticulum aminopeptidases (ERAPs) and elastase LasB from the bacterium Pseudomonas aeruginosa. ERAPs (1 and 2) are involved in the process of antigen maturation. These enzymes cleave peptide precursors into mature antigenic peptides so that they have an optimal size for their complexation to the major histocompatibility complex of class I and thus initiate or not the adaptive immune response. The expression levels of these proteases as well as single nucleotide polymorphisms have been associated with the development of cancers and autoimmune diseases. Thus, the modulation of these enzymes would allow to fight against pathologies associated with the immune system. P. aeruginosa is a Gram-negative bacterium with remarkable virulence and antimicrobial resistance. Today, antibiotic resistance represents a major public health issue and there is an urgent need for new therapeutics. In order to meet this need, new strategies have emerged such as targeting the virulence of bacteria to "disarm" them. LasB represents a therapeutic target of choice due to its extracellular localization and its physiopathological implications (colonization, invasion, evasion of immune response, biofilm formation, etc.). Although there is a clear unmet medical need in these two therapeutic areas, no modulator of ERAPs or LasB has reached the market. Thus, the use of the KTGS strategy followed by optimization phases allowed us to identify and optimize new families of ligands for these enzymes. These compounds can be considered as promising lead compounds since they present nanomolar affinities for their respective targets, selectivity and toxicity profiles as well as remarkable physicochemical properties
APA, Harvard, Vancouver, ISO, and other styles
2

Eldnes, Hilde Finstad. "Betydningen av terapeutens rolle i arbeidet med mennesker som lider av OCD : En kvalitativ studie av terapeutiske faktorer og framgangsmåter." Thesis, Karlstads universitet, Fakulteten för humaniora och samhällsvetenskap (from 2013), 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:kau:diva-37081.

Full text
Abstract:
This qualitative study was aimed at examining which therapeutic attitudes and procedures it is possible to find regarding obsessive-compulsive disorder (OCD), to see if there are any specific factors that crystallizes as particularly important for this disorder. A total of ten therapists with different background and experiences concerning OCD participated in the study where semi-structured interviews was used to collect the data. To analyze the data thematic analysis was used. Three main-themes grew from the analysis, which were all related to the study’s overall purpose. The first main-theme was general therapeutic attitudes. Under this theme, there are two sub-themes, personal characteristics of the therapist and degree of knowledge. The second main-theme, therapeutic approaches regarding OCD, also includes two sub-themes, degree of therapeutic distinctiveness and specific treatment interventions. The third main-theme was the treatment results components. This theme also includes two sub-themes, therapeutic factors and choice of method. In the participants’ stories about which therapeutic attitudes and procedures that are important regarding the treatment of people suffering from OCD, several factors became visible. These are connected to a general therapeutic attitude across diagnosis, such as warmth, empathy, and the ability to form an alliance, in addition to several therapeutic factors which are important to OCD specifically, such as experience and maturity, and being creative. The participants also emphasizes to a large degree ERP as the first choice in regards to treatment. Specifically for this study is that one participant emphasizes ACT as the preferred treatment intervention, where ERP did not result in a satisfactory treatment outcome.
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Therapeutic ERCP"

1

M, Jacobson Ira, ed. ERCP: Diagnostic and therapeutic applications. New York: Elsevier, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Neuhaus, Bernhard. Diagnostic and therapeutic ERCP: Technical aspects and atlas. Baltimore: Williams & Wilkins, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

ERCP: Diagnostic and therapeutic applications (Current topics in gastroenterology). Elsevier, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kahaleh, Michel. Therapeutic and Advanced ERCP: Gastrointestinal Endoscopy Clinics of North America. Elsevier - Health Sciences Division, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ira M., M.D. Jacobson. Ercp: Diagnostic and Therapeutic Applications (Current Topics in Gastroenterology, Vol 2). Appleton & Lange, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Abramowitz, Jonathan S. Exposure and Response Prevention in OCD. Edited by Christopher Pittenger. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190228163.003.0037.

Full text
Abstract:
This chapter describes the therapeutic approach of exposure and response prevention (ERP) for the treatment of obsessive-compulsive disorder (OCD). ERP is one of the most successful interventions for any psychological problem. The derivation of this tandem of behavioral and cognitive-behavioral procedures from early animal research and research on humans with obsessional problems and compulsive behaviors transformed OCD from an intractable condition to a remarkably treatable one during the latter half of the 20th century. This chapter provides an overview of the development and delivery of this therapy and review the latest treatment-related research. It begins with a brief synopsis of how ERP was developed, followed by a description of the contemporary approaches to using this set of techniques. Evidence for its efficacy and effectiveness is presented, followed by a discussion of future directions.
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Therapeutic ERCP"

1

Vitale, Gary C. "Therapeutic ERCP." In The SAGES Manual, 508–15. Berlin, Heidelberg: Springer Berlin Heidelberg, 1999. http://dx.doi.org/10.1007/978-3-642-88454-2_62.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Meining, Alexander, and Martin Götz. "ERCP." In Therapeutic Endoscopy in the Gastrointestinal Tract, 71–99. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-55468-6_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Mine, Tetsuya. "Introduction of ERCP." In Advanced Therapeutic Endoscopy for Pancreatico-Biliary Diseases, 7–11. Tokyo: Springer Japan, 2017. http://dx.doi.org/10.1007/978-4-431-56009-8_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bang, Ji Young, and Gregory A. Coté. "Idiopathic Acute Pancreatitis and Sphincter of Oddi Dysfunction: Diagnostic and Therapeutic Role of ERCP and Sphincter of Oddi Manometry." In ERCP and EUS, 227–42. New York, NY: Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4939-2320-5_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Fujita, Rikiya. "The History of ERCP and EUS." In Advanced Therapeutic Endoscopy for Pancreatico-Biliary Diseases, 1–4. Tokyo: Springer Japan, 2017. http://dx.doi.org/10.1007/978-4-431-56009-8_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Tsuchiya, Takayoshi, and Takao Itoi. "EUS- and Enteroscopy-Assisted ERCP." In Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy, 1–10. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-29964-4_71-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Tsuchiya, Takayoshi, and Takao Itoi. "EUS- and Enteroscopy-Assisted ERCP." In Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy, 1237–46. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-56993-8_71.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Aabakken, Lars. "ERCP in Surgically Altered Anatomy." In Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy, 1219–35. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-56993-8_70.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Aabakken, Lars. "ERCP in Surgically Altered Anatomy." In Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy, 1–17. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-29964-4_70-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Baillie, John, and Nathan J. Shores. "Sphincterotomy and Stents in Benign and Malignant Disorders and Biliary ERCP." In Diagnostic and Therapeutic Procedures in Gastroenterology, 183–93. Totowa, NJ: Humana Press, 2010. http://dx.doi.org/10.1007/978-1-59745-044-7_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Therapeutic ERCP"

1

Agar, K., M. Medhioub, S. Jardak, L. Hamzaoui, A. Khsiba, and M. Msaddek Azouz. "RISK FACTORS FOR COMPLICATIONS RELATED TO THERAPEUTIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP): AN ANALYSIS OF 505 CASES." In ESGE Days 2018 accepted abstracts. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1637659.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

De Benito, M., A. Yaiza Carbajo, S. Bazaga, FJ Garcia-Alonso, R. Sanchez-Ocaña, I. Peñas-Herrero, F. Garcia-Pajares, C. De la Serna Higuera, and M. Perez-Miranda. "TEMPORARY EUS-GUIDED ANASTOMOSES (TEA) AS THERAPEUTIC ACCESS FISTULAS (TAF) IN BENIGN BILIARY OBSTRUCTION (BBO) NOT AMENABLE TO ERCP: EMERGING APPLICATION OF EUS-GUIDED BILIARY DRAINAGE (EUS-BD)." In ESGE Days 2019. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1681449.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Therapeutic ERCP' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography